Efficacy of apatinib in patients with sorafenib-transarterial chemoembolization refractory hepatocellular carcinoma: a retrospective study.

Yanyan CaoTao OuyangFu XiongXuefeng KanLei ChenBin LiangChuangsheng Zheng

Published in: Hepatology international (2021)

In patients with sorafenib-TACE-refractory HCC, subsequent apatinib treatment significantly improved the OS when compared with supportive care, and produced comparative outcomes with those sorafenib-TACE responders.

Keyphrases

healthcare
radiofrequency ablation
palliative care
quality improvement
pain management
skeletal muscle
replacement therapy